Case Study: GSK achieves rapid, non-disruptive pharmaceutical manufacturing security with Elisity

How the Elisity platform for vigilant network security, data integrity, and life-saving measures enhances Dynamic Edge Segmentation

GSK's CISO faced the critical challenge of securing its global pharmaceutical manufacturing operations, which involved protecting the medicine supply chain. The initial plan involved a traditional firewall buildout across 75 sites, but this project was deemed budget-busting and too slow, threatening operational continuity. GSK turned to the vendor Elisity and its identity-based microsegmentation platform to find a better solution.

Elisity implemented a cloud-based identity microsegmentation architecture that profiles devices and applies policy based on identity, not network location. The results were transformative, reducing deployment time to under 30 minutes per site and allowing GSK to bring three new sites online each week. This Elisity solution provided dramatic cost reduction, rapid global deployment, and enhanced risk reduction, allowing the CISO to secure production without disruption.

GSK

Michael Elmore

Chief Information Security Officer